Danielle Marie Brander, MD

Assistant Professor of Medicine
Member of the Duke Cancer Institute
Campus mail 2400 Pratt St Suite 5000, Durham, NC 27710
Phone (919) 668-1000
Email address danielle.brander@duke.edu
In Their Words

Education and Training

  • Resident, Internal Medicine, Duke University School of Medicine, 2007 - 2010
  • M.D., Duke University School of Medicine, 2007

Grants

Publications

Eyre, Toby A., Nicole Lamanna, Lindsey E. Roeker, Chaitra S. Ujjani, Brian T. Hill, Paul M. Barr, Erick Lansigan, et al. “Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia.” Haematologica 106, no. 1 (January 1, 2021): 284–87. https://doi.org/10.3324/haematol.2019.241539.

PMID
32079693
Full Text

Hanlon, Ashley, and Danielle M. Brander. “Managing toxicities of phosphatidylinositol-3-kinase (PI3K) inhibitors.” Hematology Am Soc Hematol Educ Program 2020, no. 1 (December 4, 2020): 346–56. https://doi.org/10.1182/hematology.2020000119.

PMID
33275709
Full Text

Cuneo, Antonio, Anthony R. Mato, Gian Matteo Rigolin, Alfonso Piciocchi, Massimo Gentile, Luca Laurenti, John N. Allan, et al. “Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study.” Cancer Med 9, no. 22 (November 2020): 8468–79. https://doi.org/10.1002/cam4.3470.

PMID
32969597
Full Text

Stephens, Deborah M., Ken Boucher, Elizabeth Kander, Sameer A. Parikh, Erin M. Parry, Mazyar Shadman, John M. Pagel, et al. “Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration.” Haematologica Online ahead of print (October 5, 2020). https://doi.org/10.3324/haematol.2020.256388.

PMID
33054118
Full Text

Mato, Anthony R., Lindsey E. Roeker, Nicole Lamanna, John N. Allan, Lori Leslie, John M. Pagel, Krish Patel, et al. “Outcomes of COVID-19 in patients with CLL: a multicenter international experience.” Blood 136, no. 10 (September 3, 2020): 1134–43. https://doi.org/10.1182/blood.2020006965.

PMID
32688395
Full Text

Roeker, Lindsey E., Peter Dreger, Jennifer R. Brown, Oscar B. Lahoud, Toby A. Eyre, Danielle M. Brander, Alan Skarbnik, et al. “Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents.” Blood Adv 4, no. 16 (August 25, 2020): 3977–89. https://doi.org/10.1182/bloodadvances.2020001956.

PMID
32841336
Full Text

Mato, Anthony R., Lindsey E. Roeker, Ryan Jacobs, Brian T. Hill, Nicole Lamanna, Danielle Brander, Mazyar Shadman, et al. “Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.” Clin Cancer Res 26, no. 14 (July 15, 2020): 3589–96. https://doi.org/10.1158/1078-0432.CCR-19-3815.

PMID
32198151
Full Text

Sung, Anthony D., Shekeab Jauhari, Sharareh Siamakpour-Reihani, Arati V. Rao, Janet Staats, Cliburn Chan, Everett Meyer, et al. “Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects.” Am J Hematol 95, no. 6 (June 2020): 662–71. https://doi.org/10.1002/ajh.25781.

PMID
32162718
Full Text

Eyre, Toby A., Lindsey E. Roeker, Christopher P. Fox, Satyen H. Gohill, Renata Walewska, Harriet S. Walter, Francesco Forconi, et al. “The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.” Br J Haematol 188, no. 6 (March 2020): 918–23. https://doi.org/10.1111/bjh.16271.

PMID
31682002
Full Text

Pages